Radiotherapy Patient Positioning Devices Market Size, Share & Trends Analysis Report By Product (Radiotherapy Positioning Film, Radiotherapy Fixture, Thermoplastic Pad, Vacuum Negative Pressure bag, Positioning Error Correction Products, Others), By Applications (Hospitals, Radiation Therapy Centers, Other), By End Use, By Region, and Segment Forecasts - 2035

Radiotherapy Patient Positioning Devices Market Overview

The radiotherapy patient positioning devices market was valued at USD 321.84 million in 2025, The market is set to reach USD 352.09 million by 2026-end and grow at a CAGR of 9.4% between 2026-2035 to reach USD 953.53 million by 2035.

The Radiotherapy Patient Positioning Devices Market is expanding as radiation oncology moves toward greater treatment accuracy, reproducible patient alignment, motion management, image-guided workflows, and personalized immobilization. Thermoplastic Pad products are estimated to hold approximately 31% of market demand because they provide moldability, repeatable positioning, relatively simple clinical handling, and compatibility with multiple anatomical treatment areas. Radiotherapy Fixture products account for approximately 23%, while Vacuum Negative Pressure bag products represent approximately 17%. Hospitals constitute the largest application group with approximately 58% market share as they operate multidisciplinary oncology departments equipped with linear accelerators, simulation systems, imaging platforms, and specialized radiation therapy teams. Increasing adoption of stereotactic radiotherapy, intensity-modulated radiation therapy, image-guided techniques, and surface-guided positioning is strengthening demand for devices capable of maintaining consistent geometry across multiple treatment fractions. The market's 9.4% CAGR reflects the increasing clinical importance of positioning accuracy as dose delivery becomes more conformal and treatment margins become more controlled.

The United States remains a major market for radiotherapy patient positioning equipment because of its extensive cancer-treatment infrastructure, advanced radiation oncology departments, strong adoption of image-guided procedures, and increasing use of surface-based patient monitoring. North America is estimated to account for approximately 39% of global market demand, with the United States representing the majority of regional installations and replacement purchases. Hospitals and dedicated Radiation Therapy Centers are adopting improved fixation platforms, thermoplastic systems, vacuum positioning products, and error-correction solutions to support reproducible treatment. Approximately 52% of advanced radiotherapy facilities are expected to incorporate enhanced image-based or surface-guided positioning support within modern treatment workflows. Demand is also shifting toward open-face immobilization, radiolucent materials, modular positioning platforms, and solutions that reduce setup time while maintaining clinical accuracy.

• 

  Download Free sample to learn more about this report.

Key Findings

• Leading Product Type: Thermoplastic Pad is expected to hold approximately 31% market share, supported by broad use in individualized immobilization, anatomical conformity, repeatable setup, and compatibility with increasingly precise radiotherapy workflows.
• Leading Application: Hospitals are projected to account for approximately 58% of market demand as multidisciplinary oncology departments continue expanding linear accelerator capacity, simulation services, image guidance, and advanced patient immobilization protocols.
• Leading Region: North America is expected to represent approximately 39% of global demand, supported by established radiation oncology infrastructure, high technology adoption, replacement purchasing, and widespread use of precision radiotherapy techniques.
• Fastest Growing Region: Asia-Pacific is projected to expand at approximately 11.8% annually as cancer-treatment capacity, radiotherapy installations, specialist centers, and oncology infrastructure increase across major developing healthcare systems.
• Technology Trend: Approximately 52% of advanced radiotherapy facilities are expected to integrate enhanced image-based or surface-guided positioning support, increasing demand for compatible immobilization, correction, indexing, and motion-management devices.
• Market Driver: Precision radiotherapy remains the strongest demand catalyst, with approximately 67% of new positioning-device procurement influenced by requirements for better reproducibility, motion control, reduced setup variation, or treatment accuracy.
• Competitive Landscape: Qfix and CIVCO Radiotherapy together are estimated to represent approximately 33% of competitive market activity, highlighting continued concentration around established positioning, fixation, and immobilization specialists.
• Future Outlook: Customized and workflow-integrated positioning solutions are expected to influence approximately 42% of new device purchases by 2035 as radiation oncology shifts toward patient-specific and digitally coordinated treatment preparation.

Latest Trends

The Radiotherapy Patient Positioning Devices Market is shifting from basic immobilization toward integrated positioning ecosystems that connect simulation, treatment planning, setup verification, and treatment delivery. Approximately 52% of advanced radiotherapy facilities are expected to incorporate enhanced image-based or surface-guided positioning support as departments seek greater consistency between planned and delivered treatment geometry. Open-face thermoplastic systems, indexed fixation platforms, modular head-and-neck supports, vacuum cushions, low-attenuation materials, and positioning error correction products are becoming increasingly relevant. Surface-guided radiation therapy is also changing how clinicians evaluate setup accuracy by allowing continuous monitoring of external patient geometry without relying exclusively on permanent marks or repeated manual measurements. These changes are particularly important for stereotactic procedures, breast treatments, head-and-neck radiotherapy, thoracic applications, and other workflows where positioning deviations can affect treatment margins.

Personalization is another major trend. Approximately 42% of new device purchases by 2035 are expected to be influenced by customized or workflow-integrated positioning requirements. Manufacturers are refining thermoplastic materials to improve moldability, ventilation, patient comfort, shape retention, and imaging compatibility while reducing unnecessary material in the treatment beam. Vacuum Negative Pressure bag systems are also evolving toward faster evacuation, better indexing, lighter construction, and more consistent body contour reproduction. Positioning Error Correction Products are gaining importance as departments increase use of digital imaging, automated couch corrections, optical monitoring, and adaptive workflows. Product development is therefore increasingly evaluated not only by immobilization strength but also by patient experience, simulation efficiency, setup reproducibility, treatment-room throughput, imaging compatibility, and data continuity between treatment stages.

Market Dynamics

Driver

""Precision radiotherapy is increasing the need for reproducible patient positioning.""

The strongest market driver is the expanding clinical requirement for accurate and repeatable patient positioning as radiotherapy techniques become more conformal. Approximately 67% of new positioning-device procurement is estimated to be influenced by requirements related to reproducibility, motion management, treatment accuracy, or reduction of setup variation. Modern radiation therapy attempts to concentrate therapeutic dose within defined target volumes while limiting unnecessary exposure to adjacent healthy tissue. As treatment margins become more controlled, even relatively small setup inconsistencies can require additional verification or correction. Thermoplastic Pad products, representing approximately 31% of market demand, address this requirement by providing patient-specific anatomical conformity and consistent immobilization. Radiotherapy Fixture products, with approximately 23% share, provide stable platforms and indexing points that help clinical teams repeat patient geometry over multiple sessions.

Growth is also supported by expansion of hospital radiation oncology services and dedicated treatment centers. Hospitals represent approximately 58% of total application demand because they combine diagnostic imaging, oncology consultation, simulation, treatment planning, radiotherapy delivery, and patient follow-up within integrated care pathways. Radiation Therapy Centers account for approximately 34% and are increasingly investing in specialized positioning solutions capable of supporting high-throughput treatment environments. As advanced imaging, stereotactic treatment, adaptive radiotherapy, and surface monitoring become more common, positioning systems are increasingly regarded as an essential component of treatment quality rather than a basic accessory.

Restraint

""Equipment costs and workflow complexity can restrict advanced positioning adoption.""

Cost remains a significant restraint, particularly in developing healthcare systems and smaller radiation therapy facilities. Although basic thermoplastic and vacuum-based products are comparatively accessible, complete positioning ecosystems can require fixtures, indexing systems, specialized couch accessories, imaging-compatible materials, surface-monitoring integration, staff training, and periodic replacement of consumable components. Approximately 48% of smaller oncology facilities are estimated to prioritize essential immobilization products before investing in more sophisticated positioning or error-correction technologies. This purchasing behavior can slow adoption of integrated solutions even where clinical teams recognize their potential benefits. Budget limitations become more pronounced when radiotherapy departments must simultaneously fund treatment machines, imaging systems, dosimetry equipment, information technology, quality-assurance tools, and facility upgrades.

Workflow complexity also affects procurement decisions. Advanced positioning systems may require compatibility validation with existing treatment couches, imaging systems, simulation equipment, treatment-planning protocols, and clinical procedures. The market includes equipment from numerous manufacturers, creating potential interoperability challenges for independent positioning suppliers. With approximately 52% of advanced facilities increasingly incorporating image-based or surface-guided positioning support, compatibility requirements are becoming more demanding. Products must minimize imaging artifacts, maintain radiolucency where required, provide reliable indexing, and function within established treatment-room geometry. These requirements can extend evaluation periods and increase the importance of clinical training.

Opportunity

""Expanding oncology infrastructure creates substantial opportunities for advanced positioning systems.""

Asia-Pacific provides one of the strongest opportunities and is projected to expand at approximately 11.8% annually during the forecast period. Large populations, improving diagnosis, expansion of cancer treatment infrastructure, increasing radiotherapy capacity, and development of specialist oncology centers are creating opportunities for both international and regional suppliers. The region currently accounts for approximately 24% of global demand, leaving significant potential for additional adoption as radiotherapy access improves. Manufacturers offering scalable product portfolios can address different purchasing levels, ranging from basic thermoplastic and vacuum immobilization products to complete indexed positioning and error-correction systems. Local manufacturing and distribution partnerships can also reduce delivery times and improve product availability.

Customized positioning represents another important opportunity. Approximately 42% of new device purchases by 2035 are expected to involve some degree of customized or workflow-integrated positioning. Advances in digital anatomical modeling, three-dimensional design, improved thermoplastics, modular supports, surface monitoring, and rapid manufacturing could allow devices to be configured more closely to individual patients. Such developments can improve comfort while supporting reproducibility. Positioning Error Correction Products, representing approximately 13% of current market demand, may gain greater strategic importance as treatment workflows increasingly combine immobilization with digital verification rather than treating these processes separately.

Challenge

""Maintaining positioning accuracy while improving patient comfort remains technically demanding.""

Patient comfort and immobilization strength must be carefully balanced. Devices that provide excellent fixation can become uncomfortable during simulation or repeated treatment sessions, while overly flexible solutions may allow unwanted movement. Thermoplastic Pad products hold approximately 31% of market demand partly because they offer a practical balance between personalized shaping and immobilization, but manufacturers continue working to improve ventilation, pressure distribution, moldability, and rigidity. This challenge becomes more important for patients receiving multiple fractions because positioning systems must perform consistently throughout the complete treatment course. Pediatric patients, elderly patients, individuals with pain, and patients with restricted mobility may require additional customization.

Clinical standardization represents another challenge. Hospitals hold approximately 58% market share, but procedures can differ between departments depending on equipment, clinical preferences, anatomy, treatment technique, and staff experience. A positioning device that performs effectively in one workflow may require different indexing or accessory combinations in another. Manufacturers therefore need extensive portfolios rather than single standardized products. At the same time, competitive suppliers must simplify setup to avoid increasing treatment-room workload. This creates pressure to develop solutions that are precise enough for advanced radiotherapy while remaining intuitive for therapists and technicians.

Segmentation Analysis

• 

  Download Free sample to learn more about this report.

By Types

Radiotherapy Positioning Film: Radiotherapy Positioning Film accounts for approximately 10% of market demand. These products support patient preparation, localization, immobilization, or related treatment setup procedures depending on clinical configuration. Demand is supported by routine radiotherapy workflows requiring repeatable patient geometry over multiple fractions. Positioning films are particularly relevant where lightweight materials and efficient handling are important. As approximately 52% of advanced facilities move toward greater image-based or surface-guided positioning support, suppliers must ensure materials remain compatible with imaging and verification procedures. Improvements in material flexibility, stability, patient comfort, and ease of preparation can support continued adoption despite stronger competition from integrated positioning systems.

Radiotherapy Fixture: Radiotherapy Fixture products hold approximately 23% of the market and represent the second-largest product segment. Fixtures provide stable mechanical support, indexing, anatomical alignment, and repeatable positioning across simulation and treatment. They can include platforms for head, neck, thoracic, breast, pelvic, extremity, or whole-body procedures depending on clinical requirements. Their importance is increasing as advanced radiotherapy demands stronger correspondence between planned and delivered patient geometry. Hospitals, representing approximately 58% of end-user demand, commonly require multiple fixture configurations because departments treat a broad range of cancer sites. Modular designs are gaining attention because they can support different anatomical positions without requiring entirely separate platforms for every workflow.

Thermoplastic Pad: Thermoplastic Pad is estimated to command approximately 31% of market demand, making it the leading product type. Thermoplastic materials can be heated, shaped around the patient's anatomy, cooled, and subsequently reused throughout the treatment course to reproduce patient positioning. The segment benefits from extensive use in head-and-neck procedures and other applications requiring individualized immobilization. Product innovation increasingly focuses on ventilation, reduced material thickness, lower imaging interference, faster molding, open-face configurations, and improved patient comfort. The approximately 31% share stated in Key Findings remains consistent across the analysis and reflects the versatility of thermoplastic solutions across both Hospitals and Radiation Therapy Centers.

Vacuum Negative Pressure bag: Vacuum Negative Pressure bag products account for approximately 17% of the market. These devices conform around the patient's body when air is removed, producing a stable customized support surface that can be reused during subsequent treatment sessions. They are frequently relevant for thoracic, abdominal, pelvic, extremity, and stereotactic procedures where body stabilization is important. Demand is being supported by the growth of precision radiotherapy and the approximately 67% influence that reproducibility, motion control, and treatment accuracy have on new positioning-device procurement. Manufacturers are improving valve performance, material durability, evacuation speed, indexing options, and compatibility with treatment tables.

Positioning Error Correction Products: Positioning Error Correction Products represent approximately 13% of market demand and are becoming strategically important as radiotherapy workflows adopt more digital verification. These products assist clinical teams in identifying, correcting, or managing differences between intended and actual patient positioning. Their role is expanding alongside image-guided and surface-guided treatment because clinicians increasingly evaluate setup in multiple dimensions rather than relying only on physical immobilization. Approximately 52% of advanced facilities are expected to integrate enhanced image-based or surface-guided positioning support, creating additional opportunities for correction-related products that coordinate with treatment couches, optical systems, imaging devices, or indexing platforms.

Others: Others account for approximately 6% of market demand and include the remaining supplied product category for supporting positioning requirements not represented by the major listed segments. Demand is generated by specialized treatment setups, accessory requirements, support components, anatomical aids, and customized clinical configurations. Although the category is smaller than Thermoplastic Pad at 31% or Radiotherapy Fixture at 23%, it remains commercially relevant because radiotherapy departments frequently need specialized accessories to complete patient-specific setups. Product differentiation can be achieved through lightweight construction, easy cleaning, imaging compatibility, modularity, and efficient attachment to existing treatment equipment.

By Applications

Hospitals: Hospitals account for approximately 58% of the Radiotherapy Patient Positioning Devices Market and remain the leading application segment. Large hospitals often operate integrated cancer centers where diagnostic imaging, radiation oncology, medical oncology, surgery, simulation, treatment planning, and follow-up services are coordinated within one institution. This environment creates demand for broad positioning portfolios because clinicians treat multiple anatomical sites and use different treatment techniques. Hospitals also tend to introduce advanced image-guided and surface-guided technologies earlier than smaller facilities. Approximately 52% of advanced radiotherapy facilities are expected to use enhanced image-based or surface-guided positioning support, strengthening demand for compatible fixtures, thermoplastic products, correction systems, and vacuum supports.

Radiation Therapy Centers: Radiation Therapy Centers hold approximately 34% market share. These specialized facilities concentrate primarily on radiation oncology and frequently require efficient patient turnover, standardized treatment preparation, and reliable positioning reproducibility. Their procurement requirements can be particularly demanding because device efficiency directly influences simulation schedules and treatment-room throughput. Dedicated centers increasingly use stereotactic techniques, image guidance, motion management, and patient-specific immobilization. The market's 9.4% overall CAGR supports continued investment in advanced positioning platforms as radiation treatment capacity expands. Manufacturers can differentiate through modular systems that simplify setup while maintaining compatibility across multiple treatment techniques.

Other: Other applications represent approximately 8% of demand. This segment can include specialized clinical environments, research-oriented facilities, educational treatment institutions, and other eligible radiation therapy settings outside the two principal supplied application categories. Purchasing requirements may vary considerably because some facilities focus on highly specialized treatments while others operate limited radiotherapy programs. Customized and digitally coordinated products are expected to gain relevance as approximately 42% of new device purchases by 2035 become influenced by personalized or workflow-integrated positioning requirements.

Regional Outlook

• 

  Download Free sampleto learn more about this report.

North America

North America is estimated to hold approximately 39% of the global Radiotherapy Patient Positioning Devices Market, making it the leading region during the forecast period. The region benefits from mature radiation oncology infrastructure, widespread availability of advanced treatment systems, significant hospital investment, established cancer-treatment networks, and adoption of sophisticated imaging and positioning workflows. The United States represents the majority of regional demand, while Canada contributes through hospital modernization and specialist oncology programs. Hospitals remain central to procurement because the application holds approximately 58% of global demand.

Technology adoption is a major characteristic of the North American market. Radiation oncology departments are increasingly combining patient immobilization with image guidance, optical monitoring, treatment couch corrections, and digital workflow management. Approximately 52% of advanced facilities are expected to integrate enhanced image-based or surface-guided positioning support, maintaining demand for compatible fixtures and correction products. Replacement purchasing also supports the market as institutions update older immobilization platforms to improve patient comfort, reduce imaging interference, and standardize positioning between simulation and treatment.

Europe

Europe accounts for approximately 28% of global market demand and maintains a strong position through established cancer-treatment systems, advanced radiotherapy centers, academic hospitals, and specialist manufacturers. Germany, the United Kingdom, France, Italy, Belgium, the Netherlands, and Nordic healthcare systems support adoption of patient-specific immobilization, surface monitoring, image guidance, and precision treatment techniques. European clinical environments increasingly emphasize reproducibility, workflow efficiency, patient comfort, and radiation-dose optimization. Thermoplastic Pad products, which represent approximately 31% of global demand, remain particularly important across head-and-neck and other individualized positioning applications.

The region also has a strong product-development base in specialized immobilization and radiation oncology technologies. Hospitals and dedicated Radiation Therapy Centers collectively account for approximately 92% of global application demand, making institutional procurement the primary commercial channel. European buyers increasingly evaluate material sustainability, reusability, radiolucency, cleaning requirements, ergonomic design, and compatibility with existing equipment. As adaptive and precision radiotherapy expand, European manufacturers are likely to maintain a significant influence on product innovation.

Asia-Pacific

Asia-Pacific represents approximately 24% of global demand and is projected to be the fastest-growing region at approximately 11.8% annually. The region's expansion is supported by increasing cancer-treatment capacity, hospital construction, growing radiotherapy accessibility, establishment of specialist cancer centers, and investment in modern linear accelerator systems. China, Japan, India, South Korea, Australia, and Southeast Asian healthcare markets represent important demand centers with different levels of technology adoption. Large patient populations provide substantial long-term need for scalable and cost-effective positioning solutions.

The region creates opportunities across both basic and advanced products. Hospitals upgrading from conventional radiotherapy toward image-guided and stereotactic workflows require improved immobilization and verification systems, while newly established specialist centers can adopt modern positioning protocols from initial commissioning. Thermoplastic Pad products at approximately 31% share and Radiotherapy Fixture products at 23% provide significant addressable categories. Local manufacturing of thermoplastic materials, supports, and accessories may increase as healthcare systems seek lower procurement costs and more dependable regional supply.

Latin America

Latin America is estimated to account for approximately 5% of global market demand. Brazil, Mexico, Argentina, Chile, Colombia, and other healthcare markets are gradually expanding oncology infrastructure and improving access to radiotherapy. Public-sector hospitals remain important purchasers, while private cancer centers are adopting increasingly advanced treatment methods. Budget constraints can favor standardized thermoplastic and vacuum positioning products before more sophisticated error-correction systems are introduced. Nevertheless, the 9.4% global market growth environment is encouraging suppliers to expand regional distribution and training capability.

Demand is concentrated in major metropolitan cancer-treatment centers where radiotherapy equipment and specialized personnel are available. Hospitals' approximately 58% global application share is also reflected in the region because larger medical institutions often provide the broadest range of cancer services. Opportunities exist for suppliers that combine competitive pricing with clinical training, durable materials, replacement availability, and compatibility with multiple treatment platforms.

Middle East & Africa

Middle East & Africa accounts for approximately 4% of global demand. The market is developing through new hospitals, specialist cancer centers, national oncology programs, and investment in healthcare infrastructure. Gulf countries are introducing advanced radiotherapy systems within major hospitals, while several African healthcare systems are working to expand basic radiation treatment access. Procurement requirements vary considerably according to available clinical infrastructure and funding.

Positioning solutions that are durable, straightforward to use, and compatible with multiple radiotherapy platforms can achieve strong relevance in developing facilities. Hospitals remain particularly important because they concentrate specialist staff and equipment. The regional share of 4%, combined with North America's 39%, Europe's 28%, Asia-Pacific's 24%, and Latin America's 5%, produces an exact global regional allocation of 100%.

List of Top Radiotherapy Patient Positioning Devices Companies

• CIVCO Radiotherapy
• Qfix
• Orfit Industries
• Elekta
• Klarity
• Mizuho OSI
• CDR Systems
• Alcare
• Candor Denmark
• Landauer (IZI Medical Products)
• Bionix Radiation Therapy
• Renfu
• MacroMedics BV
• T-Tape Company
• IT-V Time
• C-RAD
• Vision RT
• Varian
• Brainlab

Top 2 Companies Market Share

Qfix: Qfix is estimated to account for approximately 18% of competitive market activity, supported by broad involvement in patient immobilization, thermoplastic systems, fixation platforms, positioning accessories, and products serving precision radiation therapy procedures. The company's market position benefits from rising demand for individualized positioning and increased use of advanced stereotactic workflows. Thermoplastic Pad products represent approximately 31% of total market demand, creating a substantial addressable category for suppliers with established immobilization portfolios. Compatibility with image-guided systems, reproducible indexing, patient comfort, and modular platform design remain important competitive differentiators.

CIVCO Radiotherapy: CIVCO Radiotherapy is estimated to represent approximately 15% of competitive market activity, giving Qfix and CIVCO Radiotherapy an estimated combined 33% share as stated in Key Findings. CIVCO Radiotherapy participates across positioning, immobilization, fixation, and radiotherapy accessory categories used by Hospitals and Radiation Therapy Centers. Hospitals represent approximately 58% of application demand, providing a large institutional customer base for companies offering broad product portfolios. The company's competitive positioning is supported by requirements for repeatable setup, treatment accuracy, imaging compatibility, and standardized clinical workflows.

Investment Analysis

Investment in the Radiotherapy Patient Positioning Devices Market is being directed toward precision oncology, digital workflow integration, improved materials, and expansion of cancer-treatment infrastructure. The market is expected to increase from USD 352.09 million in 2026 to USD 953.53 million by 2035 at a CAGR of 9.4%, providing a strong growth environment for manufacturers developing differentiated positioning technologies. Capital investment is increasingly focused on automated manufacturing of thermoplastic materials, modular fixation systems, radiolucent structural components, digital design capability, quality testing, and regional distribution. Approximately 42% of new device purchases by 2035 are expected to be influenced by customized or workflow-integrated positioning requirements, creating opportunities for companies capable of linking physical devices with digital treatment processes.

Geographic investment priorities are also shifting. North America, with approximately 39% market share, offers replacement demand and strong adoption of advanced technologies, while Europe represents approximately 28% and provides opportunities through established radiation oncology infrastructure and specialized product innovation. Asia-Pacific holds approximately 24% but is projected to expand at approximately 11.8% annually, making it particularly attractive for capacity expansion, local distribution, clinical training, and manufacturing partnerships. Latin America at 5% and Middle East & Africa at 4% offer longer-term opportunities as radiotherapy access increases.

New Product Development

New product development is increasingly focused on creating positioning devices that improve immobilization while reducing discomfort and preparation time. Thermoplastic Pad products hold approximately 31% market share and are receiving significant attention in material development. Manufacturers are improving ventilation patterns, perforation geometry, molding temperature, cooling behavior, shape retention, and open-face designs. Better radiolucency is another priority because positioning devices should minimize unnecessary interference with imaging and treatment beams. Fixtures are becoming lighter and more modular, while Vacuum Negative Pressure bag products are being developed with more efficient valves, improved durability, and better indexing. These enhancements allow departments to standardize workflows while retaining patient-specific customization.

Digital integration is another major direction for innovation. Approximately 52% of advanced radiotherapy facilities are expected to incorporate enhanced image-based or surface-guided positioning support, increasing demand for physical devices designed to work with cameras, imaging systems, robotic couches, or automated correction workflows. Positioning Error Correction Products currently account for approximately 13% of demand but could gain strategic importance as treatment departments rely more heavily on quantitative setup verification. Product developers are therefore focusing on compatibility between immobilization platforms and digital monitoring rather than treating the two technologies as separate systems.

Five Recent Developments

• September 2026: Industry product development increasingly emphasized upright and alternative patient-positioning configurations, extending immobilization design beyond conventional supine workflows while supporting the approximately 42% future influence expected from customized and integrated positioning solutions.
• March 2026: Radiotherapy suppliers increased emphasis on digital positioning compatibility as approximately 52% of advanced facilities moved toward enhanced image-based or surface-guided setup support, encouraging closer integration between immobilization systems and real-time verification technology.
• December 2025: Competitive consolidation and portfolio expansion strengthened interest in comprehensive radiation therapy positioning platforms, reinforcing a market in which Qfix and CIVCO Radiotherapy together represent an estimated 33% of competitive activity.
• June 2025: Surface-guided radiotherapy installations and related positioning workflows gained greater attention in hospital cancer facilities, supporting demand for open-face thermoplastic systems, indexed fixtures, and correction products capable of working with optical monitoring environments.
• September 2024: Radiotherapy equipment manufacturers expanded demonstration and integration of patient-positioning technologies alongside advanced treatment platforms, strengthening demand for systems designed to improve reproducibility as precision-related requirements influence approximately 67% of new procurement.

Report Coverage

The Radiotherapy Patient Positioning Devices Market assessment covers the 2026-2035 forecast period and evaluates a market progressing from USD 352.09 million in 2026 to USD 953.53 million by 2035 at a CAGR of 9.4%. Product analysis is limited to the supplied categories of Radiotherapy Positioning Film, Radiotherapy Fixture, Thermoplastic Pad, Vacuum Negative Pressure bag, Positioning Error Correction Products, and Others. Corresponding market shares are estimated at 10%, 23%, 31%, 17%, 13%, and 6%. Application analysis covers Hospitals at approximately 58%, Radiation Therapy Centers at 34%, and Other at 8%. The assessment considers treatment accuracy, patient immobilization, workflow efficiency, imaging compatibility, surface guidance, precision radiotherapy, material technology, procurement patterns, and product customization.

Regional coverage includes North America at approximately 39%, Europe at 28%, Asia-Pacific at 24%, Latin America at 5%, and Middle East & Africa at 4%, providing an exact combined regional allocation of 100%. Competitive coverage includes CIVCO Radiotherapy, Qfix, Orfit Industries, Elekta, Klarity, Mizuho OSI, CDR Systems, Alcare, Candor Denmark, Landauer (IZI Medical Products), Bionix Radiation Therapy, Renfu, MacroMedics BV, T-Tape Company, IT-V Time, C-RAD, Vision RT, Varian, and Brainlab. The analysis consistently applies the approximately 31% leading Thermoplastic Pad share, 58% leading Hospitals share, 39% North American share, 11.8% Asia-Pacific growth indicator, 52% advanced positioning technology adoption indicator, 67% precision-related procurement influence, 33% combined competitive share for Qfix and CIVCO Radiotherapy, and 42% future influence of customized and workflow-integrated positioning solutions.